Skip to main content

Fuchs Dystrophy clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Descemet Endothelial Thickness Comparison Trial II

    Sorry, not yet accepting patients

    Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.

Last updated: